To include your compound in the COVID-19 Resource Center, submit it here.

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 2/7 cls
Fluidigm Corp. (NASDAQ:FLDM) Cowen Doug Schenkel Downgrade Market perform (from outperform) -4% $43.11
Schenkel raised his target to $45 from $42, saying the company's single-cell genomics technologies and 2014 outlook are captured in the stock's price. Fluidigm reported 2013 revenues of $71.2M and expects a 23-28% increase in 2014. Schenkel is "increasingly

Read the full 799 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers